The FDA has issued a new draft guidance to direct medical device manufacturers on how to ensure power morcellator tissue containment systems are safe and will not put women at…
The FDA's final guidance on power morcellators calls for them to only be used on younger women not suspected of having cancer, and only with the use of an approved…
The FDA has issued a new draft guidance on the use of power morcellators linked to the spread of undiagnosed cancers, indicating they should only be used with adequate containment…
A new study finds that women with uterine sarcoma who undergo morcellation face a significantly higher risk of death.
The FDA reports that risks of contracting uterine cancer from power morcellation could be as high as 1-in-225, and also warns that cancer spread through morcellation appears to be more…
A long-ignored technique known as embolization may be an under-used means of uterine fibroid removal, according to a new study. which comes as the medical community abandons morcellation procedures due…
A GAO report indicates that the FDA's adverse reporting system and its voluntary nature may have delayed the agency from detecting heightened cancer risks linked to the use of power…
Olympus has received approval for a new morcellator equipped with a tissue containment bag, amid concerns that morcellators can spread cancerous cells throughout a woman's body.
Researchers have seen no increase in hysterectomy complications as the medical community walks back from power morcellator use over cancer fears, according to a new study.
A congressman is urging the administration to include a medical device review and monitoring process as part of the "Cancer Moonshot" initiative, specifically calling for a review of power morcellators…
